Sonida Senior Living
Sonida Senior Living's revenue rose 25.2% to $381 million in fiscal 2025. Its net margin was −18.6%, down from −0.7% a year earlier. Free cash flow was −$9 million. The diluted share count rose 28.2%.
Net margin is net income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
What Sonida Senior Living does
Sonida Senior Living owns, operates and invests in senior housing communities in the United States. It says it has provided senior housing since 1990. Its communities mainly serve people aged 75 and older, with independent living, assisted living and memory care. Many communities offer all three, so residents can move between levels of care as their needs change.
Most of its revenue comes from residents, many of whom pay for their housing and services themselves. Some funding comes from government programs. The company owns most of its communities and also manages some for a third party. It says the industry is very competitive and some competitors have more money than it does.
On March 11, 2026, Sonida completed the purchase of CNL Healthcare Properties, a non-traded real estate investment trust, through a merger. That brought in a national portfolio of senior housing communities. Most are run by third-party managers, and some are leased to other operators under triple-net leases, where the tenant pays property taxes, insurance, utilities and repairs. Two are skilled nursing facilities, which provide rehabilitation and nursing care.
Its biggest risks, as it describes them
- Significant debt, and the chance it cannot cover required interest and principal payments.
- Integrating the CNL Healthcare Properties merger, including unknown liabilities and expected benefits that may not come.
- Depending on residents who pay for themselves, and on changes to government reimbursement.
- Competition in senior living, and residents leaving or ending their agreements.
- Rising labor costs and staff shortages, and liability for the care it provides.
Income statement
Sonida Senior Living lost money in fiscal 2025: a net loss of $71 million.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 79 | 17 | 4 | 17 | 11 |
| Debt incl. finance leases | 683 | 671 | 629 | 651 | 690 |
| Net debt (negative means net cash) | 605 | 654 | 625 | 634 | 679 |
| Net debt to EBITDA | 3.0x | 38.1x | 6.4x | 5.6x | 29.2x |
| Debt to equity | — | — | — | 9.1x | — |
| Interest coverage | 4.4x | −0.6x | 1.6x | 1.9x | −0.9x |
| Current ratio | 0.9x | 0.5x | 0.3x | 0.8x | 0.7x |
| Quick ratio | 0.9x | 0.5x | 0.3x | 0.8x | 0.7x |
Cash flow
Projections
Project Sonida Senior Living's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
Insider trades
No officer, director or 10% owner of Sonida Senior Living reported buying or selling its shares on the open market between November 14, 2025 and November 13, 2026.
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY23 | FY24 | FY25 |
|---|---|---|---|
| Piotroski F-score | 4 of 8 | 5 of 8 | 3 of 8 |
| Rule of 40 | 4.2% | 10.3% | 22.9% |
| Altman Z'' | −2.47 | −1.05 | −2.37 |
| Accruals ratio | −5.0% | −0.0% | −11.3% |
The nine F-score tests
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Fail | Fail | Fail |
| Cash from operations is positive | Pass | Fail | Pass |
| Return on assets rose | Pass | Pass | Fail |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Fail | Pass | Pass |
| Current ratio rose | Fail | Pass | Fail |
| Share count didn't rise | Fail | Fail | Fail |
| Gross margin rose | — | — | — |
| Revenue rose relative to assets | Pass | Pass | Fail |
| F-score | 4 of 8 | 5 of 8 | 3 of 8 |
Compare
Put Sonida Senior Living side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Sonida Senior Living | FY25 | 25.2% | — | −2.3% | −3.8% | 29.2x | 3 | |
| U.S. Physical Therapy | FY25 | 16.3% | 11.1% | 7.8% | 10.7% | 1.2x | 6 | Compare |
| Nutex Health | FY25 | 82.4% | 31.5% | 28.1% | 40.3% | 0.5x | 7 | Compare |
| National Healthcare | FY25 | 16.1% | 8.5% | 9.8% | 9.4% | −0.3x | 6 | Compare |
| Astrana Health | FY25 | 56.4% | 2.5% | 3.3% | 4.2% | 4.9x | 4 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 447 | 467 | 460 | 447 | 384 | 235 | 238 | 255 | 304 | 381 |
| Revenue growth | 8.6% | 4.4% | −1.5% | −2.8% | −14.1% | −38.9% | 1.6% | 7.1% | 19.2% | 25.2% |
| Gross profit | — | — | — | — | — | — | — | — | — | — |
| Research and development | — | — | — | — | — | — | — | — | — | — |
| Operating income | 14 | 8 | 8 | −15 | — | — | — | 58 | 69 | — |
| Net income | −28 | −44 | −54 | −36 | −295 | 126 | −54 | −21 | −2 | −71 |
| Diluted EPS (US$) | −14.55 | −22.50 | −26.97 | −17.87 | −144.08 | 37.92 | −9.27 | −3.85 | −0.54 | −4.22 |
| Diluted shares (millions) | 2 | 2 | 2 | 2 | 2 | 3 | 6 | 7 | 14 | 18 |
| Cash flow | ||||||||||
| Cash from operations | 52 | 56 | 37 | 5 | −7 | −29 | −3 | 11 | −2 | 24 |
| Capital expenditure | 62 | 40 | 22 | 20 | 16 | 10 | 25 | 18 | 25 | 33 |
| Free cash flow | −10 | 16 | 15 | −15 | −22 | −39 | −27 | −7 | −27 | −9 |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share buybacks | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 139 | 85 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-based compensation | 12 | 8 | 8 | 2 | 2 | 3 | 4 | 3 | 4 | 5 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 34 | 18 | 31 | 24 | 18 | 79 | 17 | 4 | 17 | 11 |
| Debt incl. finance leases | — | — | — | — | 909 | 683 | 671 | 629 | 651 | 690 |
| Total assets | 1,146 | 1,183 | 1,149 | 1,268 | 703 | 729 | 661 | 622 | 842 | 845 |
| Total liabilities | 1,029 | 1,102 | 1,114 | 1,253 | 982 | 734 | 719 | 688 | 712 | 789 |
| Shareholders' equity | 117 | 80 | 35 | 14 | −279 | −47 | −102 | −115 | 72 | −0 |
| Margins and ratios | ||||||||||
| Gross margin | — | — | — | — | — | — | — | — | — | — |
| Operating margin | 3.2% | 1.7% | 1.6% | −3.3% | — | — | — | 22.7% | 22.6% | — |
| Net margin | −6.3% | −9.5% | −11.7% | −8.1% | −77.0% | 53.5% | −22.8% | −8.3% | −0.7% | −18.6% |
| Free cash flow margin | −2.3% | 3.4% | 3.2% | −3.4% | −5.8% | −16.7% | −11.4% | −2.8% | −8.9% | −2.3% |
| Rule of 40 (growth + FCF margin) | 6.3% | 7.7% | 1.8% | −6.2% | −20.0% | −55.6% | −9.8% | 4.2% | 10.3% | 22.9% |
| Return on capital | — | — | — | — | — | 27.8% | −3.0% | 8.6% | 8.9% | −3.8% |
| Return on equity | −22.2% | −44.8% | — | — | — | — | — | — | — | — |
| Return on assets | −2.6% | −3.8% | −4.6% | −3.0% | −30.0% | 17.6% | −7.8% | −3.3% | −0.3% | −8.4% |
| Net debt to EBITDA | — | — | — | — | — | 3.0x | 38.1x | 6.4x | 5.6x | 29.2x |